• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿石症与囊性纤维化。

Urolithiasis and cystic fibrosis.

作者信息

Matthews L A, Doershuk C F, Stern R C, Resnick M I

机构信息

Department of Urology, University Hospitals of Cleveland, Ohio 44106-5046, USA.

出版信息

J Urol. 1996 May;155(5):1563-4.

PMID:8627822
Abstract

PURPOSE

We determined whether cystic fibrosis patients are at increased risk for the development of urolithiasis.

MATERIALS AND METHODS

Telephone interviews were conducted with 201 cystic fibrosis patients older than 15 years to identify those with a history of urolithiasis. Histories were confirmed by chart review, and only patients with urolithiasis documented by excretory urography, renal ultrasound or spontaneous passage of a stone were included.

RESULTS

A total of 11 patients (5.5%) had documented urolithiasis, with 2 or more episodes in 7. Mean age at initial episode was 27.0 years (range 19 to 33).

CONCLUSIONS

Cystic fibrosis patients may be at increased risk for urolithiasis compared to age-specific prevalence rates for stone disease in the general population.

摘要

目的

我们确定囊性纤维化患者发生尿路结石的风险是否增加。

材料与方法

对201名15岁以上的囊性纤维化患者进行电话访谈,以确定有尿路结石病史的患者。通过查阅病历确认病史,仅纳入经排泄性尿路造影、肾脏超声检查证实有尿路结石或结石自行排出的患者。

结果

共有11名患者(5.5%)有记录在案的尿路结石,其中7名患者有2次或更多发作。首次发作的平均年龄为27.0岁(范围19至33岁)。

结论

与一般人群中按年龄划分的结石病患病率相比,囊性纤维化患者发生尿路结石的风险可能增加。

相似文献

1
Urolithiasis and cystic fibrosis.尿石症与囊性纤维化。
J Urol. 1996 May;155(5):1563-4.
2
Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.吸收性高草酸尿症会增加囊性纤维化患者患尿路结石或肾钙质沉着症的风险。
Am J Kidney Dis. 2005 Sep;46(3):440-5. doi: 10.1053/j.ajkd.2005.06.003.
3
Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.囊性纤维化患者的胰腺炎:与胰腺状态和基因型的相关性
Pediatrics. 2005 Apr;115(4):e463-9. doi: 10.1542/peds.2004-1764. Epub 2005 Mar 16.
4
[Age of onset of urolithiasis: relation to clinical and metabolic risk factors].[尿石症的发病年龄:与临床和代谢危险因素的关系]
Arch Esp Urol. 2004 Mar;57(2):119-25.
5
Radiation exposure in the acute and short-term management of urolithiasis at 2 academic centers.两所学术中心尿路结石急性和短期治疗中的辐射暴露情况。
J Urol. 2009 Feb;181(2):668-72; discussion 673. doi: 10.1016/j.juro.2008.10.012. Epub 2008 Dec 18.
6
[Clinico-epidemiologic behavior of urolithiasis in a rural Caribbean region].[加勒比海农村地区尿路结石症的临床流行病学行为]
Arch Esp Urol. 2002 Jun;55(5):527-33; discussion 533-4.
7
Local factors compared with systemic factors in the formation of bladder uric acid stones.膀胱尿酸结石形成中局部因素与全身因素的比较
Urol Int. 2009;82(1):48-52. doi: 10.1159/000176025. Epub 2009 Jan 20.
8
[Clinico-epidemiologic study of urolithiasis in a Caribbean urban area].[加勒比海城市地区尿路结石病的临床流行病学研究]
Nefrologia. 2002;22(3):239-44.
9
[Risk of urolithiasis in patients with cystic fibrosis].[囊性纤维化患者的尿路结石风险]
Nefrologia. 2009;29(1):61-6. doi: 10.3265/Nefrologia.2009.29.1.61.1.en.full.pdf.
10
Pediatric urolithiasis--evaluation of risk factors in 95 children.小儿尿石症——95例儿童危险因素评估
Scand J Urol Nephrol. 2003;37(2):129-33. doi: 10.1080/00365590310008866.

引用本文的文献

1
Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis.三联CFTR调节剂疗法对囊性纤维化患者肾脏的影响。
Clin Kidney J. 2024 Aug 27;17(10):sfae256. doi: 10.1093/ckj/sfae256. eCollection 2024 Oct.
2
Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion.囊性纤维化跨膜调节因子的缺失会损害肠道草酸盐分泌。
J Am Soc Nephrol. 2017 Jan;28(1):242-249. doi: 10.1681/ASN.2016030279. Epub 2016 Jun 16.
3
Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
草酸降解微生物或草酸降解酶:哪一种是复发性结石病中草酸钙尿石酶促溶解的未来治疗方法?
Urolithiasis. 2016 Feb;44(1):45-50. doi: 10.1007/s00240-015-0845-6. Epub 2015 Dec 8.
4
Renal diseases in adults with cystic fibrosis: a 40 year single centre experience.成人囊性纤维化患者的肾脏疾病:40年单中心经验
J Nephrol. 2015 Oct;28(5):585-91. doi: 10.1007/s40620-015-0179-z. Epub 2015 Feb 25.
5
Secretion of biologically active heterologous oxalate decarboxylase (OxdC) in Lactobacillus plantarum WCFS1 using homologous signal peptides.利用同源信号肽在植物乳杆菌 WCFS1 中分泌具有生物活性的异源草酸盐脱羧酶(OxdC)。
Biomed Res Int. 2013;2013:280432. doi: 10.1155/2013/280432. Epub 2013 Jul 18.
6
Predisposing factors for nephrolithiasis and nephrocalcinosis in cystic fibrosis.囊性纤维化中肾结石和肾钙沉着症的易感因素。
Iran J Pediatr. 2011 Mar;21(1):65-71.
7
Heterologous expression of oxalate decarboxylase in Lactobacillus plantarum NC8.草酸脱羧酶在植物乳杆菌NC8中的异源表达。
Curr Microbiol. 2009 Feb;58(2):117-21. doi: 10.1007/s00284-008-9286-6. Epub 2008 Oct 23.
8
Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis.乳酸双歧杆菌草酰辅酶A脱羧酶基因的鉴定与异源表达
Appl Environ Microbiol. 2004 Sep;70(9):5066-73. doi: 10.1128/AEM.70.9.5066-5073.2004.
9
DNA sequencing and expression of the formyl coenzyme A transferase gene, frc, from Oxalobacter formigenes.产甲酸草酸杆菌中甲酰辅酶A转移酶基因(frc)的DNA测序及表达
J Bacteriol. 1997 May;179(10):3378-81. doi: 10.1128/jb.179.10.3378-3381.1997.